Common Contracts
2 similar Placement Agency Agreement contracts by Hollis Eden Pharmaceuticals Inc /De/
4,000,000 Shares HOLLIS-EDEN PHARMACEUTICALS, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 8th, 2006 • Hollis Eden Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
Hollis-Eden Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to certain investors (collectively, the “Investors”) up to an aggregate of 4,000,000 shares (the “Shares”) of the Company’s Common Stock, par value $0.01 per share (the “Common Stock”). Each Investor shall also receive a warrant, in the form of Exhibit A attached hereto, to purchase up to a number of shares of the Company’s Common Stock (the “Warrant Shares”) equal to 20% of the Shares purchased by such Investor, at an exercise price equal to $8.75 per share, exercisable beginning six months after issuance and on or prior to the fourth anniversary of issuance (the “Warrants”). The Shares, the Warrant and the Warrant Shares (collectively, the “Securities”) have been registered on a registration statement on Form S-3, File No. 333-135095 (the “Registration Statement”), which has been declared effective by the Securities and Exchange Commission (“SEC”), and remains effective as of the dat
4,000,000 Shares HOLLIS-EDEN PHARMACEUTICALS, INC. Common Stock PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • February 2nd, 2006 • Hollis Eden Pharmaceuticals Inc /De/ • Pharmaceutical preparations • New York
Hollis-Eden Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to certain investors (collectively, the “Investors”) up to an aggregate of 4,000,000 shares (the “Shares”) of the Company’s Common Stock, par value $0.01 per share (the “Common Stock”). Each Investor shall also receive a warrant, in the form of Exhibit A attached hereto, to purchase up to a number of shares of the Company’s Common Stock (the “Warrant Shares”) equal to 20% of the Shares purchased by such Investor, at an exercise price equal to $8.75 per share, exercisable beginning six months after issuance and on or prior to the fourth anniversary of issuance (the “Warrants”). The Shares, the Warrant and the Warrant Shares (collectively, the “Securities”) have been registered on a registration statement on Form S-3, File No. 333-126458 (the “Registration Statement”), which has been declared effective by the Securities and Exchange Commission (“SEC”), and remains effective as of the dat
